Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization-Reference-Cited by-同舟云学术

Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization

Published:2023-07 Issue:7 Volume:30 Page:726-738.e4
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

McConnell Scott A.^ORCID,Sachithanandham Jaiprasath,Mudrak Nathan J.,Zhu Xianming,Farhang Parsa Alba,Cordero Radames J.B.,Wear Maggie P.,Shapiro Janna R.,Park Han-Sol,Klein Sabra L.,Tobian Aaron A.R.,Bloch Evan M.,Sullivan David J.,Pekosz Andrew,Casadevall Arturo^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference73 articles.

1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat. Rev. Microbiol.,2020

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

3. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation;Wrapp;Science,2020

4. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen;Pallesen;Proc. Natl. Acad. Sci. USA,2017

5. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding;Gui;Cell Res.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating miRNAs in the Plasma of Post-COVID-19 Patients with Typical Recovery and Those with Long-COVID Symptoms: Regulation of Immune Response-Associated Pathways;Non-Coding RNA;2024-09-02

2. Considerations for the development of monoclonal antibodies to address new viral variants in COVID-19;Expert Opinion on Biological Therapy;2024-08-02

3. Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins;Biomedicines;2024-05-02

4. ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients;mBio;2024-04-10

5. Catalytic Protein Inhibitors;Angewandte Chemie International Edition;2024-01-12